AND my I add AND they are estimating loss in the next 2 quarters ( on average ).. I just do not see how you can announce a -40%+ revenure SHORTFALL with PRICE CUTTING PRESSURES and turn a profit? Raj the MAGICIAN obviously lost a trick or too versus the generic COMPETITION.. AND I might add AND I do not see where if your wholesalers stopped ordering because the END USERS STOPPED buying in the same QUANTITY as before the software that tracts the end users will fix the problem? The problem is the end users demand is only buying $80m - $90m instead of the $214m 2013 Fusilev record sales. LETS SEE what the sales will be for Folotyn and Zevalin? LETS SEE if Raj the MAGICIAN can work some of his MAGIC on Zevalin like he has been PUMPING? LETS SEE if the NEW ( overstaffed ) DREAM SALES TEAM can increase Folotyn sales? Keller has his work cut out for him. For all those long the Matrix is BLINDLY CHEERING for you... I hope and pray that SPPI can stick to the $170m middle guidance and turn A PROFIT!!!